<DOC>
	<DOCNO>NCT02762110</DOCNO>
	<brief_summary>Evaluate feasibility use novel image test , [ 18F ] ISO-1 PET/CT image sigma-2 receptor bind cancer . Correlate uptake standard experimental pathology assay biopsy surgical tissue . The target population 30 adult patient least 18 year , know suspect breast cancer least one lesion 1.0 cm size least one type standard imaging .</brief_summary>
	<brief_title>Imaging In Vivo Sigma-2 Receptor Expression With 18FISO-1 Positron Emission Tomography ( PET/CT ) Primary Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>At least 18 year age Known suspected breast cancer least one breast lesion 1 cm great size standard imaging ( e.g . mammography , ultrasound breast MRI ) . Only one type imaging require show lesion 1 cm great order patient eligible participate study . Patients prior diagnosis primary breast cancer opposite breast include . Participants must inform investigational nature study provide write informed consent accordance institutional federal guideline prior studyspecific procedure . Females pregnant time screen eligible study , urine serum pregnancy test perform woman childbearing potential time screen . Inability tolerate imaging procedure , opinion investigator treat physician . Serious unstable medical psychological condition , opinion investigator , would compromise subject 's safety successful participation study . Unwilling unable provide inform consent . Only individual ( age 18 ) understand give inform consent approach participate study . Individuals consider mentally disabled recruit study . All subject must understand able give inform consent . The investigator use specific method assess decisional capacity . Economically disadvantaged person vulnerable undue influence , study offer compensation . All individual tell choice regard study participation way change access clinical care . This negate undue influence coercion . Children , fetuses , neonate , prisoner include research study . The menopausal status study participant review screen process examine patient 's chart , woman childbearing potential serum urine pregnancy test time screening .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>